REFERENCES
  1. Anzilotti C, Swan DJ, Boisson B, et al. An essential role for the Zn 2+ transporter ZIP7 in B cell development.Nat Immunol . 2019;20:350-361.
  2. Kambe T, Hashimoto A, Fujimoto S. Current understanding of ZIP and ZnT zinc transporters in human health and diseases. Cell Mol Life Sci . 2014;71:3281-3295.
  3. Erdős M, Lányi Á, Balázs G, Casanova JL, Boisson B, Maródi L. Inherited TOP2B mutation: Possible confirmation of mutational hotspots in the TOPRIM domain. J Clin Immunol . 2021;41:817-819.
  4. Tangye SG, Al-Herz W, Bousfiha A, et al. Human inborn errors of immunity: 2019 update on the classification from the international union of immunological societies expert committee. J Clin Immunol . 2020;40:24-64.
  5. Feske S, Gwack Y, Prakriya M, et al. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature . 2006;441:179-185.
  6. Li FY, Chaigne-Delalande B, Kanellopoulou C, et al. Second messenger role for Mg2+ revealed by human T-cell immunodeficiency.Nature . 2011;475:471-476.
  7. Woodruff, G. et al. The zinc transporter SLC39A7 (ZIP7) is essential for regulation of cytosolic zinc levels. Mol Pharmacol . 2018;94:1092-1100.
  8. Maródi L and the J Project Study Group. Fifteen years of the J Project. J Clin Immunol . 2019; 39:636-639.
  9. Tuzankina I, Bolkov M, Nabieva U, Lázár I, Maródi L. The J Daughter Siberia Project. J Clin Immunol . 2021;41:262-265.
  10. Maródi L and the J Project Study Group. The 10thanniversary of World Primary Immunodeficiency Week: A J Project celebration. Eur J Immunol . 2021; 51: 2364–2366.